Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Katlama: Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-.... (0.16 sec) 

Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and …

- annals.org
C Katlama, MA Valantin, S Matheron, A … - Annals of internal …, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: A combination of
two nucleoside analogues is currently the core of any antiretroviral regimen for HIV-1 ...
Cited by 51 - Related articles - BL Direct - All 4 versions

Stavudine resistance: an update on susceptibility following prolonged therapy.


PF Lin, CJ Gonzalez, B Griffith, G Friedland, V Calvez … - Antiviral therapy, 1999 - ncbi.nlm.nih.gov
The current report summarizes the available published and unpublished data from several investigators
on resistance in clinical isolates following prolonged stavudine therapy. Results suggest that
stavudine resistance is both modest in degree and infrequent in appearance. Phenotypic ...
Cited by 45 - Related articles - BL Direct - All 3 versions

Genotypic and phenotypic analysis of human immunodeficiency virus type 1 …


PF Lin, H Samanta, RE Rose, AK Patick, J Trimble, … - The Journal of infectious …, 1994 - jstor.org
JID 1996; 174 (October) MAP Kinase Activation by Peptidoglycan ... MOL Research
Laboratories, Plymouth Meeting, PA), rolipram (Berlex Laboratories, Wayne, NJ), or
forskolin. The stimulants (sPGN, ReLPS, or PDB) were then added for the indicated lengths
Cited by 107 - Related articles - BL Direct - All 3 versions

Lack of emergence of genotypic resistance to stavudine after 2 years of …


V Soriano, U Dietrich, N Villalba, A Immelmann, A Gil- … - AIDS, 1997 - csa.com
Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy. V Soriano,
U Dietrich, N Villalba, A Immelmann, A Gil-Aguado, S Echevarria, B Clotef, I Ocana, JM Santamaria,
E Bouza, V Barona, JM Gatell, J Gonzalez-Lahoz AIDS 11:55, 696-697, 4/1997. ...
Cited by 34 - Related articles - BL Direct - All 3 versions

Mutations conferring resistance to zidovudine diminish the antiviral effect of …


J Izopet, A Bicart-See, C Pasquier, K … - Journal of medical …, 1999 - interscience.wiley.com
This study evaluated the influence of zidovudine (ZDV) resistance mutations on the antiviral effect
of the combination of stavudine (D4T) plus didanosine (ddI) in patients treated previously with
ZDV plus zalcitabine (ddC). Twenty patients who had been treated with ZDV plus ddC for ...
Cited by 74 - Related articles - BL Direct - All 4 versions

Stavudine plus lamivudine in advanced human immunodeficiency virus disease: a …


D Rouleau, B Conway, J Raboud, S Rae, S … - The Journal of …, 1997 - UChicago Press
Page 1. 1156 Stavudine plus Lamivudine in Advanced Human Immunodeficiency
Virus Disease: A Short-Term Pilot Study Danielle Rouleau, Brian Conway, Janet
Raboud, AIDS Research Program, British Columbia Centre for ...
Cited by 15 - Related articles - BL Direct - All 5 versions

Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients


JE Gallant, RE Chaisson, JC Keruly, RD Moore - AIDS, 1999 - journals.lww.com
Skip Navigation Links Home > February 4, 1999 - Volume 13 - Issue 2 > Stavudine in zidovudine
(ZDV)-experienced compared with ZDV-... ... Gallant, Joel E.; Chaisson, Richard E.; Keruly, Jeanne
C.; Moore, Richard D. ... From the Johns Hopkins University School of Medicine, ...
Cited by 9 - Related articles - All 3 versions

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from …


EP Coakley, JM Gillis, SM Hammer - Aids, 2000 - journals.lww.com
From the Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical
Center and Harvard Medical School, Boston, Massachusetts, and the a Division of Infectious
Diseases, Department of Medicine, Columbia University College of Physicians and ...
Cited by 114 - Related articles - All 4 versions

Human immunodeficiency virus-infected persons with mutations conferring …


JSG Montaner, T Mo, JM Raboud, S Rae, CS … - The Journal of …, 2000 - UChicago Press
Featured in US News & World Report "Common Cold Virus Alters Body's Genes" October
24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus
(RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine


C de Mendoza, V Soriano, C Briones, O … - JAIDS Journal of …, 2000 - journals.lww.com
To the Editor: The activity of antiretroviral drugs seems to be compromised to some extent when
compounds of the same family are used in second-line therapies (1,2). For instance, the antiviral
effect of stavudine (d4T) is reduced in persons previ- ously exposed to zidovudine (ZDV) ...
Cited by 29 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google